ArticlePloS one2020

Odiparcil, a potential glycosaminoglycans clearance therapy in mucopolysaccharidosis VI-Evidence from in vitro and in vivo models.

Eugeni Entchev et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.